Skip to main content

Release not found

This press release isn’t in the live store anymore. Open the original on the wire, or jump into the live feed.

Go to feed
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE), for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients · AbbVie · PPN World